Duolink Proximity Ligation Assay for PKC-θ and ZEB1
Corresponding Organization : QIMR Berghofer Medical Research Institute
Other organizations : Australian Regenerative Medicine Institute, Monash University, St John of God Hospital, Canberra Hospital, Australian National University, Charles Sturt University, Monash Health, Peter MacCallum Cancer Centre, University of Melbourne, University of Queensland, Translational Research Institute, Royal Brisbane and Women's Hospital
Variable analysis
- Primary antibodies targeting PKC-θ-Thr538p and ZEB1
- Protein-protein interactions between PKC-θ-Thr538p and ZEB1 as measured by the Duolink proximity ligation assay
- Cells were fixed, permeabilized, and incubated with primary antibodies
- Cells were processed according to the manufacturer's recommendations
- Coverslips were mounted onto slides and examined as above
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!